Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 10:11:761521.
doi: 10.3389/fcimb.2021.761521. eCollection 2021.

Insights Into the Changing Landscape of Coronavirus Disease 2019

Affiliations
Review

Insights Into the Changing Landscape of Coronavirus Disease 2019

Ruby A Escobedo et al. Front Cell Infect Microbiol. .

Abstract

Coronavirus disease 2019 (COVID-19) is a highly contagious, infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in late 2019 in Wuhan China. A year after the World Health Organization declared COVID-19 a global pandemic, over 215 million confirmed cases and approximately 5 million deaths have been reported worldwide. In this multidisciplinary review, we summarize important insights for COVID-19, ranging from its origin, pathology, epidemiology, to clinical manifestations and treatment. More importantly, we also highlight the foundational connection between genetics and the development of personalized medicine and how these aspects have an impact on disease treatment and management in the dynamic landscape of this pandemic.

Keywords: COVID epidemiology; COVID origin; COVID treatment; COVID-19; SARS-CoV-2; coronavirus; targeted therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Phylogenetic tree of SARS-CoV-2 and other related coronaviruses.
Figure 2
Figure 2
The rapid spread of COVID-19 worldwide.

References

    1. Agarwal A., Chen A., Ravindran N., To C., Thuluvath P. J. (2020). Gastrointestinal and Liver Manifestations of COVID-19. J. Clin. Exp. Hepatol. 10, 263–265. doi: 10.1016/j.jceh.2020.03.001 - DOI - PMC - PubMed
    1. Ahn D. G., Shin H. J., Kim M. H., Lee S., Kim H. S., Myoung J., et al. (2020). Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J. Microbiol. Biotechnol. 30, 313–324. doi: 10.4014/jmb.2003.03011 - DOI - PMC - PubMed
    1. Alanagreh L. A., Alzoughool F., Atoum M. (2020). The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights Into Potential Drugs and Its Mechanisms. Pathog. (Basel Switzerland) 9, 331. doi: 10.3390/pathogens9050331 - DOI - PMC - PubMed
    1. Astuti I., Ysrafil (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An Overview of Viral Structure and Host Response. Diabetes Metab. Syndr. 14, 407–412. doi: 10.1016/j.dsx.2020.04.020 - DOI - PMC - PubMed
    1. Azkur A. K., Akdis M., Azkur D., Sokolowska M., Van De Veen W., Brüggen M.-C., et al. (2020). Immune Response to SARS-CoV-2 and Mechanisms of Immunopathological Changes in COVID-19. Allergy 75, 1564–1581. doi: 10.1111/all.14364 - DOI - PMC - PubMed

Publication types